Abstract Background and Aims. Prevalence of H. pylori antibiotic resistance is increasing
worldwide, and it is the main factor affecting efficacy of current therapeutic regimens. Our …

Helicobacter pylori (H. pylori) affects nearly half of the world's population and, thus, is one of
the most frequent and persistent bacterial infections worldwide. H. pylori is associated with …

Background Helicobacter pylori is associated with benign and malignant diseases of the
upper gastrointestinal tract, and increasing antibiotic resistance has made alternative …

Background Antimicrobial resistance of Helicobacter pylori (H. pylori) affects the efficacy of
eradication therapy. The aim of this study was to estimate the prevalence of primary and …

Eradication therapy for Helicobacter pylori is recommended in a number of clinical
conditions. In this article, we discuss the epidemiology and cellular mechanisms that result …

Therapeutic management of Helicobacter pylori (H. pylori) remains an unsolved issue.
Indeed, no therapeutic regimen is able to cure the infection in all treated patients, and in …

Infection with the Gram-negative pathogen Helicobacter pylori (H. pylori) has been
associated with gastro-duodenal disease and the importance of H. pylori eradication is …

Erythromycin, the first macrolide antibiotic discovered, has been used since the early 1950s
for the treatment of upper respiratory tract and skin and soft tissue infections caused by …

Antibiotic resistance in Helicobacter pylori is the major cause of eradication failure. Primary
H. pylori susceptibility patterns, however, are becoming less predictable. Currently, high (≥ …

Background Antibiotic resistance is a leading cause of treatment failure in Helicobacter
pylori infection. In Africa, there are very little data concerning the susceptibility of …